Prima Biomed Ltd

PRR0.0250 (0.00%)17/1 at close
View full PRR analysis
Volume
Shares Issued
2,362,662,532
Dividend Yield
Market Cap
59,066,563.3
Price Book Value
PER
-5.56
PRR.ASX full report delivery
PRR
Send Report
The free stock analysis report of PRR will arrive soon. Your email provider may divert this report to a folder other than your inbox. If you don’t receive the report, please call 1-888-658-7638. Thank You.
Page 10 of 10
  1. Explanation...

    emilchahine Hey guys just wondering why all of a sudden, buyers are stacking up with this stock? Any thoughts, ideas?
    0
    Replies
    128
    Views
  2. TRADING HALT!

    engforsustainability Hi all, What's everyones views on the trading halt announced by PRR. Another major announcement similar to the cancer patent tha
    0
    Replies
    172
    Views
  3. Something cookiing, volume, i like the chart

    yawatsac Something cookiing, volume, i like the chart
    0
    Replies
    134
    Views
  4. Considerable buy

    fabcat Hi Layla.. Don't be so hard on yourself, it was a good pick on the day, you just didn't sell. You could have made a great profit
    20
    Replies
    726
    Views
  5. MAYBE THE DIRECTOR IS NO FOOL

    fabcat BJT You came to me...I didn't come to you. Bye.
    8
    Replies
    401
    Views
  6. What value cancer cure? in dollar terms?

    formerUser Kopp has clarified that he is not a director of Bluscan and also if you do the math he sold out at around 6c so I dont know wher
    10
    Replies
    439
    Views
  7. SLOWLY AWAKENING FROM A COMA

    Meta4 It seems to have trouble getting past 8c. Happy to get a nice profit on something today so I'm out at 7.9.
    19
    Replies
    549
    Views
  8. Tips comment

    Wilson! Based on the incredible hype and the potential for such a company maker with a cancer treatment, it seems it will be a goldmine
    0
    Replies
    134
    Views
  9. another EGO up almost 200 %

    tedfox would you still think it is a good time to buy?
    4
    Replies
    170
    Views
  10. bio waste

    rusty Good luck im out.. i paid some prr wages so it was an ethical way to gain a capital loss..that was easy.. now to find to find th
    0
    Replies
    211
    Views
  11. lookin good

    rusty Why the sudden interest ?somethings brewing in bio land... any idea anyone? welcome new holders
    0
    Replies
    148
    Views
  12. Tailspin

    rusty No dig taken JC...The news.. the potential..a hunch.. basicly for some of the wrong analytical reasons. I guess with that billio
    2
    Replies
    133
    Views
  13. ANNOUNCEMENT

    mrpositive333 Extremely positive announcement from company. Positive clinical results. Estimated US$1.9 billion v AUD $100m for ovarian cancer
    0
    Replies
    129
    Views
  14. Another comeback.

    Holiday PRR- up 32%.
    0
    Replies
    155
    Views
  15. Interesting Chart boiling up here

    Stoptocks Looks like there has been a little buying over the last few days.
    0
    Replies
    209
    Views
  16. Completes recruitment of Phase IIa clinical trial

    nikko Public release date: 12-Oct-2005 Contact: Daniella Goldberg 61-416-211-067 Research Australia Therapeutic vaccine for ovarian ca
    0
    Replies
    242
    Views
  17. Trillium Therapeutics acquires Arthron

    nikko Immunity specialist Trillium Therapeutics acquires Arthron Ltd. Canadian Press Thursday, October 06, 2005 TORONTO (CP) - Trilliu
    0
    Replies
    492
    Views
  18. Fast move

    ljeyaret Doing well honey
    0
    Replies
    213
    Views
Page 10 of 10
Your browser is too old for TopStocks and not secure. Please update your browser